Histidine

The dosage of Histidine varies significantly based on the route of administration and the underlying clinical indication. For general nutritional support in Parenteral Nutrition (PN), the dose is calculated based on the patient's total protein requirements, typically ranging from 2% to 6% of the total amino acid content. For a standard adult, this may translate to approximately 1.5 to 4 grams of histidine per day delivered intravenously.

When used as an oral supplement for specific conditions like rheumatoid arthritis (investigational) or nutritional deficiency, doses typically range from 1,000 mg to 4,500 mg per day, often divided into two or three doses. However, clinical studies have utilized doses as high as 8 grams daily for short periods under strict medical supervision.

In pediatric populations, especially neonates and infants, Histidine is an essential amino acid. In neonatal parenteral nutrition, the recommended intake is higher relative to body weight than in adults to support rapid growth and brain development. Typical doses range from 150 mg to 250 mg per kilogram of body weight per day. For older children, the dose is adjusted based on age, weight, and metabolic status. Oral supplementation in children is not standard and should only be conducted under the guidance of a pediatric metabolic specialist.

Renal Impairment

Patients with chronic kidney disease (CKD) often have low plasma levels of histidine. While supplementation may be beneficial, healthcare providers must monitor blood urea nitrogen (BUN) and creatinine levels closely. Nitrogen load must be carefully balanced in patients with advanced renal failure to prevent uremia.

Hepatic Impairment

In cases of severe hepatic impairment or hepatic encephalopathy, the metabolism of all amino acids is compromised. Histidine dosage may need to be reduced to prevent the accumulation of nitrogenous waste products and ammonia. Frequent monitoring of liver function tests and serum ammonia is required.

Elderly Patients

No specific dosage adjustments are generally required for elderly patients solely based on age. However, because older adults are more likely to have decreased renal function, the total nitrogen load from amino acid therapy should be monitored to prevent strain on the kidneys.

• Oral Supplements: Histidine is best taken on an empty stomach, at least 30 minutes before a meal or two hours after, to minimize competition with other amino acids for absorption. It should be swallowed whole with a full glass of water.
• Intravenous Administration: This must be performed by a healthcare professional in a clinical setting. The infusion rate should be controlled to prevent 'refeeding syndrome' or metabolic complications.
• Storage: Oral forms should be stored at room temperature (59°F to 86°F), away from moisture and direct sunlight. Do not store in the bathroom.

If you are taking oral Histidine and miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular timing. Do not double the dose to catch up, as this can lead to an imbalance in amino acid levels.

Signs of a Histidine overdose (hyperhistidinemia) may include severe nausea, vomiting, loss of appetite, and a noticeable 'histamine-like' reaction such as intense flushing, headache, or dizziness. In extreme cases, it may lead to metabolic imbalances or zinc deficiency. If an overdose is suspected, contact a poison control center or seek emergency medical attention immediately.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking Histidine without medical guidance, especially if it is part of a complex nutritional or metabolic treatment plan.

When taken at standard nutritional doses, Histidine is generally well-tolerated. However, some individuals may experience:

• Gastrointestinal Distress: This includes mild nausea, stomach cramping, or a feeling of bloating. This is most common when taking large oral doses on an empty stomach.
• Loss of Appetite: Some patients report a temporary decrease in hunger, particularly when starting supplementation.
• Altered Taste: A metallic or unusual taste in the mouth may occur shortly after administration.

• Headache: Some users report mild to moderate tension-type headaches.
• Dizziness: A feeling of lightheadedness, especially when moving from a sitting to a standing position.
• Flushing: A sensation of warmth, redness, or tingling in the face, neck, or chest. This is thought to be due to the conversion of histidine into histamine, which can cause vasodilation (widening of blood vessels).

• Zinc Deficiency: Prolonged high-dose histidine use can lead to increased urinary excretion of zinc because histidine acts as a chelating agent (a substance that binds to metals). Symptoms include hair loss, skin lesions, and impaired wound healing.
• Folate Depletion: Because the metabolism of histidine requires folate, extremely high doses can theoretically strain folate reserves in individuals with marginal intake.
• Neurological Changes: In very rare instances, high levels of histidine may affect sleep patterns or mood due to its role as a precursor to the neurotransmitter histamine.

> Warning: Stop taking Histidine and call your doctor immediately if you experience any of these serious symptoms:

• Anaphylaxis or Severe Allergic Reaction: Symptoms include hives, difficulty breathing, swelling of the face, lips, tongue, or throat. This is more likely if histidine is a component of an allergenic extract injection.
• Severe Metabolic Acidosis: If used in parenteral nutrition, an imbalance in amino acids can lead to increased blood acidity. Symptoms include rapid breathing, extreme fatigue, and confusion.
• Hyperammonemia: In patients with underlying liver issues, amino acid supplementation can lead to high ammonia levels. Seek help for sudden confusion, tremors, or lethargy.
• Profound Weakness: This may indicate a significant electrolyte or mineral imbalance (such as zinc or copper depletion).

The most significant risk of long-term, high-dose Histidine therapy is the induction of secondary mineral deficiencies. Histidine has a high affinity for divalent metal ions. Over months of use, this can lead to clinically significant zinc deficiency. Healthcare providers typically recommend monitoring zinc levels or co-supplementing with zinc if long-term histidine therapy is required. Additionally, there is a theoretical risk that chronic high histamine levels (derived from histidine) could exacerbate conditions like acid reflux or certain types of chronic inflammation in sensitive individuals.

No FDA black box warnings for Histidine. As a naturally occurring amino acid and a standard component of human nutrition, it does not carry the high-risk profile associated with potent synthetic pharmaceuticals. However, this does not mean it is without risk; it must be used appropriately within nutritional guidelines.

Report any unusual symptoms or persistent side effects to your healthcare provider. Monitoring through regular blood tests is the best way to ensure that histidine levels remain within a safe, therapeutic range.

Histidine is a potent metabolic precursor and should not be viewed as a 'simple' supplement. Because it is the direct precursor to histamine, it can significantly influence the body's inflammatory and allergic pathways. Patients with a history of severe allergies or mast cell activation disorders should use Histidine only under strict medical supervision. Furthermore, its ability to bind to essential minerals like zinc means that it can inadvertently cause nutritional deficiencies if not managed correctly.

No FDA black box warnings for Histidine. It is generally recognized as safe (GRAS) when used as a food additive and is a standard component of FDA-approved parenteral nutrition products.

• Allergic Reactions / Anaphylaxis Risk: While histidine itself is rarely the cause of an allergy, it is often used in Standardized Insect Venom Allergenic Extracts [EPC]. In these cases, the risk of anaphylaxis is high due to the venom, not the histidine. Patients receiving these treatments must be monitored in a clinical setting equipped for emergency resuscitation.
• Nitrogen Balance and Renal Risk: In patients with kidney disease, the nitrogen from histidine must be processed by the liver and kidneys. Excessive intake can lead to an accumulation of nitrogenous waste, potentially worsening uremia.
• Folate Deficiency: Histidine metabolism is a 'folate-sink.' If you are already deficient in folic acid, taking Histidine can worsen this deficiency, leading to megaloblastic anemia or other complications. Your doctor may check your folate levels before starting high-dose therapy.
• Zinc Chelation: Histidine is a known chelator. It can pull zinc out of the tissues and increase its excretion in the urine. This is a major precaution for those taking doses higher than 2 grams daily for extended periods.

If you are receiving Histidine as part of a medical treatment plan, your healthcare provider will likely require the following tests:

• Serum Amino Acid Profile: To ensure histidine levels are therapeutic and not toxic.
• Zinc and Copper Levels: To monitor for chelation-induced deficiencies.
• BUN and Creatinine: To assess kidney function and nitrogen processing.
• Liver Function Tests (LFTs): To ensure the liver is adequately metabolizing amino acids.
• Folate Levels: To prevent secondary vitamin deficiency.

Histidine generally does not cause drowsiness or cognitive impairment. However, if you experience dizziness or flushing after taking a dose, you should avoid driving or operating heavy machinery until the symptoms subside.

Alcohol can interfere with the metabolism of amino acids and may exacerbate the 'flushing' sensation associated with histidine-to-histamine conversion. It is generally advised to limit alcohol consumption while on therapeutic doses of Histidine to prevent gastrointestinal irritation and metabolic strain.

There is no known 'withdrawal syndrome' associated with stopping Histidine. However, if you are using it for a specific metabolic condition or as part of parenteral nutrition, stopping suddenly can cause a relapse of nutritional deficiencies. Always consult your doctor before discontinuing a prescribed amino acid regimen.

> Important: Discuss all your medical conditions, especially kidney disease, liver disease, and vitamin deficiencies, with your healthcare provider before starting Histidine.

There are no absolute drug-drug contraindications where Histidine must never be used; however, it should be avoided in patients with Histidinemia, a rare genetic metabolic disorder where the body cannot break down histidine. In these individuals, taking Histidine can lead to toxic accumulations in the blood and brain, potentially causing intellectual disabilities.

• Zinc Supplements: Histidine and zinc interact in a complex way. While histidine can help transport zinc, high doses of histidine significantly increase zinc excretion. If you take both, they should be dosed at different times of the day to prevent the histidine from immediately chelating the supplemental zinc.
• Methotrexate: This chemotherapy and autoimmune drug is a folate antagonist. Since histidine metabolism requires folate, taking Histidine with methotrexate can exacerbate folate depletion and increase the risk of methotrexate toxicity (e.g., mouth sores, low white blood cell counts).

• Antihistamines (H1 and H2 Blockers): Drugs like loratadine (Claritin) or famotidine (Pepcid) block the receptors that histamine acts upon. Since Histidine increases histamine production, it may theoretically reduce the perceived efficacy of these medications or require dosage adjustments.
• MAO Inhibitors (MAOIs): Monoamine oxidase inhibitors can slow the breakdown of histamine. Combining MAOIs with Histidine may lead to an excessive buildup of histamine, resulting in severe flushing, palpitations, and headaches.
• Other Amino Acids: High doses of Histidine can compete with other large neutral amino acids (like phenylalanine, tyrosine, and tryptophan) for transport across the blood-brain barrier. This could potentially affect the synthesis of neurotransmitters like dopamine and serotonin.

• High-Protein Meals: Consuming Histidine with a high-protein meal can reduce its specific absorption because it must compete with other amino acids for transport. For therapeutic effect, it is often taken away from meals.
• Alcohol: As noted, alcohol may increase the risk of histamine-related side effects like flushing and headache.

• Folic Acid / Folate: This is a beneficial interaction. Supplemental folate is often recommended alongside histidine to ensure the metabolic pathway to glutamic acid remains open.
• Quercetin: This flavonoid is a natural mast cell stabilizer. It may modulate the conversion or release of histamine from histidine, potentially altering its effects.

• FIGLU Test: Histidine loading is actually used as a diagnostic tool (the FIGLU test) to detect folate deficiency. Taking Histidine supplements will naturally increase FIGLU levels in the urine, which could lead to a false-positive result for folate deficiency if the lab is not aware of the supplementation.
• Urinary Zinc Tests: Histidine will significantly increase the amount of zinc found in a 24-hour urine collection.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete 'brown bag' review of your supplements is essential when starting amino acid therapy.

Histidine must NEVER be used in the following circumstances:

• Histidinemia: This is an inborn error of metabolism characterized by a deficiency of the enzyme histidase. Supplementing with histidine in these patients leads to dangerously high levels of histidine and its metabolites (like imidazolepyruvic acid) in the blood and urine, which can be neurotoxic.
• Hypersensitivity: Any known severe allergic reaction to L-histidine or any component of the specific formulation (such as the lipids in a lipid emulsion or the proteins in an allergenic extract).

Conditions requiring careful risk-benefit analysis before using Histidine include:

• Severe Hepatic Failure: In patients with cirrhosis or end-stage liver disease, the liver's ability to process the nitrogen from amino acids is severely impaired. This can lead to hyperammonemia and hepatic encephalopathy. Histidine should only be used in these patients if the benefits of nutritional support outweigh the risks of neurological decline.
• Active Peptic Ulcer Disease: Because histidine is a precursor to histamine, and histamine stimulates gastric acid secretion via H2 receptors, high doses could theoretically worsen stomach ulcers or gastroesophageal reflux disease (GERD).
• Folate Deficiency: In patients with known megaloblastic anemia or severe folate deficiency, histidine should be used cautiously and only with concurrent folate supplementation to prevent further metabolic 'bottlenecks.'
• Pregnancy with Phenylketonuria (PKU): While not directly contraindicated, amino acid balances are critical in PKU pregnancies, and any single-amino acid supplementation must be managed by a metabolic specialist.

There is little evidence of cross-sensitivity between histidine and other amino acids. However, patients who are sensitive to histamine-rich foods (sometimes called 'histamine intolerance') may find that they react poorly to histidine supplements, experiencing symptoms similar to an allergic reaction despite not having a true IgE-mediated allergy.

> Important: Your healthcare provider will evaluate your complete medical history, including any genetic screenings or metabolic tests, before prescribing Histidine as part of a therapeutic regimen.

FDA Pregnancy Category: Not formally assigned (typically treated as Category C).

Histidine is a naturally occurring amino acid and is essential for fetal development. During pregnancy, maternal histidine levels naturally decline as the amino acid is actively transported across the placenta to the fetus. While standard dietary intake is safe and necessary, the safety of high-dose oral supplementation (above nutritional requirements) has not been established in controlled clinical trials. High doses should only be used if clearly needed and prescribed by a doctor. There is no evidence of teratogenicity (birth defects) at nutritional doses.

Histidine is a normal component of human breast milk. Supplementation by the nursing mother is generally considered safe as long as it stays within normal nutritional ranges. It is unknown if high-dose maternal supplementation significantly alters the histidine concentration in breast milk or if it affects the nursing infant. Caution is advised with supra-nutritional doses.

Histidine is essential for infants. Without adequate histidine, infants develop a characteristic skin rash (eczema-like), impaired growth, and low hemoglobin levels. It is a standard and required component of all infant formulas and pediatric parenteral nutrition. In children with specific metabolic disorders, histidine levels must be monitored to ensure they are sufficient for growth but not so high as to cause metabolic stress.

Clinical studies have not identified specific problems that would limit the use of histidine in the elderly. However, older adults are more likely to have age-related declines in renal function. Since the kidneys are responsible for clearing the nitrogenous byproducts of histidine metabolism, healthcare providers should monitor the glomerular filtration rate (GFR) and adjust the total protein/amino acid intake accordingly to avoid uremia.

Patients with chronic kidney disease (CKD) often exhibit a unique 'histidine deficiency' despite adequate protein intake, which may contribute to the anemia of chronic disease. While supplementation is sometimes used, it must be done with extreme care. Dose adjustments are based on the patient's BUN, creatinine, and overall nitrogen balance. In patients on dialysis, histidine is cleared during the procedure, and replacement may be necessary as part of post-dialysis nutrition.

In patients with Child-Pugh Class C hepatic impairment, the clearance of amino acids is significantly delayed. Histidine should be used at the lowest effective dose, with frequent monitoring for signs of ammonia toxicity. If signs of encephalopathy (confusion, 'flapping' tremors) appear, histidine and other non-essential amino acids should be restricted.

> Important: Special populations require individualized medical assessment. Never start a supplement during pregnancy or for a child without consulting a qualified medical professional.

Histidine's primary molecular mechanism is its role as a structural precursor. It is incorporated into proteins via tRNA-mediated translation. Its unique imidazole ring allows it to participate in acid-base catalysis in enzymes like carbonic anhydrase and various proteases. Furthermore, it is the sole precursor for histamine via the action of the pyridoxal phosphate-dependent enzyme histidine decarboxylase. In the brain, this histamine acts as a neurotransmitter regulating arousal and appetite. In the stomach, it triggers the parietal cells to secrete hydrochloric acid. In the immune system, it is stored in mast cells and basophils, ready for release during an inflammatory response.

The pharmacodynamic effects of histidine are largely indirect, mediated through its metabolites histamine and carnosine. The time to onset for metabolic effects (like improved nitrogen balance) is typically 24-48 hours of consistent intake. The duration of effect for a single oral dose is approximately 6-8 hours. Tolerance to histidine does not typically develop, as it is a primary nutrient; however, the body can upregulate histidase enzymes in response to chronic high intake, slightly increasing the rate of clearance over time.

| Parameter | Value |

|---|---|

| Bioavailability | 75% - 90% (Oral) |

| Protein Binding | <5% (as free amino acid) |

| Half-life | 2 - 4 hours |

| Tmax | 1.5 - 2 hours |

| Metabolism | Hepatic (Histidase, Folate-dependent) |

| Excretion | Renal (<5% unchanged), Metabolic (as CO2 and Urea) |

• Molecular Formula: $C_6H_9N_3O_2$
• Molecular Weight: 155.15 g/mol
• Solubility: Soluble in water (41.9 g/L at 25°C); insoluble in ether and ethanol.
• Structure: An alpha-amino acid containing an imidazole functional group. It is one of the basic amino acids due to the nitrogen atoms in the ring.

Histidine is classified as an Amino Acid [EPC]. Within the therapeutic area of nutrition, it is grouped with other essential and semi-essential amino acids used for metabolic support. It is also categorized as a pharmaceutical aid (buffering agent) in the manufacture of various biological medications.